Cerebrovascular Degeneration Is Related to Amyloid‐β Protein Deposition in Alzheimer's Diseasea
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Current evidence is not inconsistent with the suggestion that cerebrovascular functions decline during normal aging with pronounced effects in both sporadic and familial Alzheimer's disease (AD). The primary causes of these changes remain unknown. It is possible that amyloid β (Aβ) protein is involved in the degeneration of both the larger penetrating vessels as well as the cerebral capillaries that represent the blood‐brain barrier (BBB). Aβ‐induced endothelial changes could also alter muscular tone, resulting not only in increased expression of vascular amyloid precursor protein (APP) and production of Aβ, but also in oxidative injury. We used immunochemical methods to examine the status of the perfusing cerebral vessels and the microvascular endothelium in relation to deposition of Aβ in AD and non‐AD aging control subjects. Double‐immunostaining with antibodies to vascular markers revealed marked loss of smooth muscle in larger vessels and absence or attenuation of the endothelium in capillary profiles that still appeared to retain their basement membranes. These vascular changes were predominantly restricted to neocortical regions abundant in Aβ deposits. Quantitative studies showed that the microvascular abnormalities were correlated to Aβ deposition rather than neurofibrillary tangles or neuronal numbers. Our studies suggest that Aβ irrespective of its origin within vascular myocytes or brain parenchyma, is responsible not only for cerebral amyloid angiopathy, but also for the degeneration of the cerebral microvasculature, which may profoundly affect brain perfusion and BBB functions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
β-Amyloid-mediated vasoactivity and vascular endothelial damage
Thomas, T., Thomas, G., McLendon, C., Sutton, T., & Mullan, M. (1996) · Nature · doi:10.1038/380168a0 · Cited by 703
Wisniewski, H. M., Wegiel, J., Wang, K. C., & Lach, B. (1992) · Acta Neuropathologica · doi:10.1007/bf00311383 · Cited by 221
Cited by
Cerebral microvascular pathology in aging and Alzheimer's disease
Farkas, E., & Luiten, P. G. M. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00068-x · Cited by 1,102
“…though the cerebrovascular cell types may not produce Ab themselves, Ab is still seriously toxic to all the endothelium, the SMCs and the pericytes (Kalaria, 1997; Price et al., 1997; Suo et al., 1997; Thomas et al., 1997; Verbeek et al., 1997; Jancso et al., 1998) and can contribute to the…”
BackgroundThe role of microglia in amyloid clearance from the AD brain
Lee, C. Y. D., & Landreth, G. E. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0433-4 · Cited by 701
“However, it is noteworthy that in the later stage of AD, BBB break down has been reported in human patients and mouse models (Kalaria 1997; Skoog et al. 1998; Wisniewski et al. 1997).”
BackgroundNeuroinflammation in Alzheimer disease
Heneka, M. T., van der Flier, W. M., Jessen, F., Hoozemanns, J., Thal, D. R., Boche, D., Brosseron, F., Teunissen, C., Zetterberg, H., Jacobs, A. H., et al. (2025) · Nature Reviews Immunology · doi:10.1038/s41577-024-01104-7 · Cited by 638
Oxidative stress and β-amyloid protein in Alzheimer’s disease
Cai, Z., Zhao, B., & Ratka, A. (2011) · NeuroMolecular Medicine · doi:10.1007/s12017-011-8155-9 · Cited by 279
“Ab deposition in the brain has been associated with increased oxidative stress, leading to oxidative modification of proteins and conse- quently to neurotoxicity and neurodegeneration (de la Torre and Mussivand 1993; Kalaria 1997).”
BackgroundGovindpani, K., McNamara, L. G., Smith, N. R., Vinnakota, C., Waldvogel, H. J., Faull, R. L., & Kwakowsky, A. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8050651 · Cited by 275
Metadata
- Authors
- KALARIA, R. N.
- Venue
- Annals of the New York Academy of Sciences
- Publisher
- Wiley
- Published
- 1997-09
- Volume
- 826
- Issue
- 1
- Pages
- 263-271
- ISSN
- 0077-8923 (ISSN-L)
- 1749-6632
- OpenAlex
- W1971667491
- Cited by
- 109
- References
- 2
- FWCI
- 4.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cerebrovascular Degeneration Is Related to Amyloid‐β Protein Deposition in Alzheimer's Diseasea. https://app.cochat.ai/papers/10.1111/j.1749-6632.1997.tb48478.x
- The paper
- KALARIA, R. N. (1997). Cerebrovascular Degeneration Is Related to Amyloid‐β Protein Deposition in Alzheimer's Diseasea. Annals of the New York Academy of Sciences. https://doi.org/10.1111/j.1749-6632.1997.tb48478.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.